Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Consumer Safety topic
No spam. Unsubscribe anytime.
Committee advances bill requiring med spa disclosure of medical director and delegation status
Summary
The Senate Health and Human Services Committee voted to send House Bill 1024 to the Committee of the Whole after testimony from the Department of Regulatory Agencies and the Colorado Nurses Association supporting consumer disclosures and postings of medical director information at med spas.
The Senate Health and Human Services Committee moved House Bill 1024, a consumer‑protection bill for medical aesthetic services (commonly called med spas), to the Committee of the Whole with a favorable recommendation following sponsor remarks and witness testimony.
Senator Cindy Roberts introduced the bill and said it is intended to increase consumer transparency where delegation allows unlicensed individuals to perform aesthetic procedures. “Many consumers have no idea that they may be receiving treatments from somebody who is completely unlicensed,” Roberts said, describing constituent concerns that spurred the measure.
Sam Delp, Division Director for the Division of Professions and Occupations at the Colorado Department of Regulatory Agencies (DORA), testified in support. DORA’s presentation said the bill would require posting of a med spa’s medical or nursing director’s license and contact information in a conspicuous place, and require a written disclosure to patients that the person performing the procedure may be a delegatee and provide the DORA complaint website for reporting harms.
Mark Longshore, Executive Director of the Colorado Nurses Association, also testified in support and described instances where unlicensed or differently licensed individuals were providing injections and other procedures. Longshore said the bill is designed to give patients clearer information and to reinforce informed consent for aesthetic procedures.
Committee members asked clarifying questions about the substances commonly used as “fillers” and the witnesses answered that while exact chemical compositions vary by product, these are injectables intended to reduce wrinkles by augmenting tissue volume.
After the witness and amendment phases concluded with no committee amendments offered, Senator Roberts moved the bill to the Committee of the Whole with a favorable recommendation. The committee recorded a favorable committee vote and reported HB1024 out of committee 7–2.
The bill’s requirements, as described by DORA and witnesses, are limited to consumer disclosures and conspicuous postings; the legislation does not itself restrict delegation authority under medical practice acts, nor does it create new licensing categories. DORA and the Colorado Nurses Association told the committee they support the measure as a consumer‑information and safety step.
